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Abstract

Prognostic markers derived from standard ECG have always been seductive.
Increased dispersion of durations of the P wave, of the QRS complex, or of the QT
interval has been associated with the risk of atrial fibrillation, ventricular
arrhythmias, sudden cardiac death, as well as with a general negative prognosis in
various settings.
However, these markers have intrinsic and methodological issues that question
their utility. This paper presents data supporting the utility of QRS dispersion in
clinical practice. Our investigation shows that QRS dispersion is a simple
electrocardiographic marker with potential value in the assessment of patients in a
variety of clinical settings: ischemic heart disease, heart failure, and
cardiomyopathies.
More studies are needed to validate QRS clinical utility for predicting the risk
for ventricular arrhythmias and sudden cardiac death, and for the evaluation of the
response to cardiac resynchronization therapy.
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Introduction

In this paper, we review studies supporting the need

QRS complex refers to the combination of three of
the

graphical

deflections

seen

on

a

typical

electrocardiogram (ECG). QRS dispersion is defined as
the difference between the maximum and minimum
QRS duration measured in the standard twelve lead
ECG. It has been suggested that an increased QRS
dispersion (QRSd) is a marker of inhomogeneous
ventricular depolarization and could be associated with

for continued research into QRSd and argue that
abandoning its potential utility should not occur just
because

of

insufficient

knowledge

regarding

its

electrophysiological basis.

Discussion
Does QRS dispersion have an electrophysiological
basis? Differences in excitation times of the normal
human heart

negative prognosis (1).
Dispersion of surface ECG wave durations or

Durrer et al., as early as in 1970, reviewed several

intervals (P wave, QRS, QT interval, JT interval) has studies and considered: ‘‘knowledge of the time course
been assiduously studied in the search for non-invasive and instantaneous distribution of the excitatory process
cardiac markers useful in predicting the risk of atrial of the normal human heart would be of value for
fibrillation, ventricular arrhythmia, and sudden cardiac understanding the QRS complex’’ (5).
death, and also as nonspecific prognosis markers. The

They studied seven re-perfused normal human hearts

largest body of data refers to QT dispersion (QTd), but, which were removed within half an hour after death.
after an initial flurry of positive results, the potential Electrocardiograms

taken before death were not

significance of QT dispersion slowly entered into suggestive of heart disease. The hearts were maintained
obscurity, due to a number of fundamental issues (2). under physiological conditions for conducting the study,
The most important criticism is based on the way the with cardiac electrical activity recorded using epicardial
ECG is constructed and derived from the projection of and intramural electrodes. The overall pattern of the left
the electrical activity loops. It has been suggested that, at ventricle (LV) depolarization showed the synchronous
least in limb leads, QT-d is an ‘illusion’. Other excitation of 3 endocardial areas, 0-5 ms after the start of
methodological issues in QT dispersion are associated depolarization:

(1) an area on the upper anterior

with its poor reproducibility, mostly due to the difficulty paraseptal wall, extending toward the apex into the
of identifying T wave offset. Some authors have region anterior papillary muscle insertion; (2) a central
extended the same arguments to P wave dispersion (3), area on the left side of the interventricular septum; and
but the question arises as to whether they also affect (3) the posterior paraseptal area. These areas of electrical
QRS dispersion.

activation extend into the next 5-10 ms, and merge at 15-

As Batchvarov stated (4) ‘‘the clinical significance 20 ms after the onset of excitation. At this time, the
of an ECG marker should be proved or disproved on the activation front envelops a great part of the ventricular
basis of its reproducibility and its link to important cavity except for a postero-basal area, a middle lateral
clinical events or other clinical variables (or lack area, and an apical anterior area. This movement around
thereof). Attempts to bolster its clinical significance by the cavity is much more rapid than the spread toward the
speculating

about

underlying

electrophysiological epicardium. Activation of the right ventricle starts 5-10

mechanism (for example in manuscripts reporting purely ms after that of LV, near anterior papillary muscle
clinical ECG studies) should be discouraged’’.

insertion, then spreads to the septum and free wall.
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Epicardial breakthrough is recorded in the pre-trabecular approximate

marker

of

this

in

homogeneous

area after 20 ms, reaching pulmonary conus and the depolarization.
postero-basal area at 60-70 ms. The epicardial excitation
QRS dispersion in myocardial infarction patients
pattern reflects the intramural excitation wave.

Perkiömäki and colleagues studied a set of 100

Cassidy et al. performed an endocardial mapping of patients: 30 healthy subjects, 40 patients with a history
the sinus rhythm in 15 patients without known heart of myocardial infarction (MI), without arrhythmic events
disease (6). Their results are similar to the findings of or

inducible

ventricular

tachycardia

(VT)

at

Durrer et al.; furthermore they suggested that, after electrophysiological study (EPS), and 30 patients with
initial activation, electrical activity spreads radially and prior MI and history of cardiac arrest (12 patients) or VT
rapidly from these breakthrough points to converge at (18 subjects) and inducible monomorphic VT at
the apex and finally the infero-posterior base. The electrophysiological study (8). Although the focus was
observation that the apex is activated ‘relatively late’ QT dispersion (QTd), QRSd was also measured. QRS
(last 25% of left ventricular endocardial activation) had
not been noted previously. Left ventricular endocardial
activation began at 0-15 ms after the QRS complex
onset. Endocardial activation of LV was completed at
29-52 ms. The duration of LV endocardial activation
was 28-50 ms. This comprised 41% of the total surface
QRS complex (mean QRS duration 87 ms, range 80-100
ms).

dispersion was 28 ± 11 ms in the normal group, 46 ± 13
ms in the group with MI and no VT, and 48 ± 16 ms in
the group with MI and VT (p < 0.001 between patients
without VT vs. healthy subjects and between patients
with VT vs. healthy subjects). The maximal and minimal
QRS duration were also higher in patients with prior MI
compared to healthy subjects (p < 0.001).
A more extensive study which included 724 patients
(9) showed that increased QRS duration (> 110 ms) or

Wyndham et al. (7) recorded the epicardial dispersion was not correlated with arrhythmic events,
ventricular depolarization sequence in 11 patients with and also QRS dispersion was not correlated with death
normal QRS who were suffering from coronary artery during follow-up.
disease and underwent heart surgery. They concluded
The effect of therapy of acute MI on QRSd was
that their data could be useful as a basis for comparison analyzed mostly indirectly in studies with other main
with the abnormal epicardial activation sequence in targets. Moreno et al., in a pre-primary PCI era study,
ventricular pre-excitation and ventricular tachycardia. analyzed the effect of thrombolysis on QTd and QRSd
Knowledge of the range of normality in epicardial (10). They included 244 patients with AMI treated with
activation sequence could also provide a basis for streptokinase or anistreplase. Dispersion of QT, JT, and
interpretation of the disordered sequence seen in chronic QRS were measured at 9 ± 5 days after thrombolytic
or surgically induced intraventricular conduction defects. therapy by using a computerized method. The maximal
The heterogeneity and conduction delays described QRS interval was 93 ± 11 ms and was observed in a
above are relevant to the basis for the QRS dispersion precordial lead in 56% of patients and from one of the
(QRSd) existence, even in the normal heart and in limb leads in 44%. The minimal QRS interval was 68 ±
different clinical situations in which the myocardium 10 ms and was noticed in a precordial lead in 39% of
depolarization is affected. Precordial leads reflect local patients and in limb leads in 61%. The average QRSd
electrical activity, and thus QRS dispersion is an was 24 ± 9 milliseconds (range: 6 - 58 ms). QRSd was
134
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not correlated with the perfusion grade observed at months, with cardiac death as the end-point (12). QRS
coronary angiography (25 ± 10 ms in grade TIMI 0, 22 ± dispersion was measured using computer software. QRS
7 ms in grade TIMI 1, 28 ± 9 ms in grade TIMI 2, and 24 dispersion was increased in non-survivors (54 ± 17 ms
± 9 ms in grade TIMI 3; p = 0.24).

vs. 46 ± 16 ms, p < 0.02). Also, patients with sudden

Mozos studied 16 patients (13 men, 3 women) with death had significantly higher QRSd compared to
prior MI (occurring at least one year prior), searching for survivors (56 ± 13 ms vs. 46 ± 16 ms, p < 0.02). Using a
correlations between signal-averaged late ventricular cut-off value of 46 ms for QRSd identified a group with
potentials (LVP) and 12-lead ECG dispersion indices high risk of death in three years (mortality 13% vs. 32%,
(QRS, QT and JT intervals) (11). Patients with relative risk 3.85, 95% confidence interval 1.6 to 9.5).
hypokalemia, hypocalcemia, or hypomagnesaemia and The risk was even higher by adding QTd> 90 ms. In a
those not in sinus rhythm were excluded. There were 6 multivariate

regression

analysis,

QRSd

was

an

patients in class III NYHA heart failure. QRS dispersion independent predictor of cardiac death (p = 0.001) and of
was measured manually using at least 8 leads for each sudden cardiac death (p = 0.04).
patient.

The

following

parameters

regarding

Yamada et al. studied 87 patients with left

depolarization were calculated: QRS dispersion (QRSd), ventricular ejection fraction (LVEF) less than 40%
QRSdc (heart rate corrected QRSd), QRScmax (heart (measured by magnetic resonance imaging) (13).
rate corrected maximum QRS duration) and QRScmin Cardiac mortality was higher in patients with both
(heart rate corrected minimum QRS duration). The abnormal QRSd (> 25 ms) and QTcd (> 62 ms), with
values were compared in two groups of patients: with better positive predictive value than in those with just
and without LVP (62.5% had LVP+). The depolarization one abnormal parameter (63% vs 15%, p = 0.01).
dispersion parameters had the following values: QRSd =

QRS dispersion was incorporated into a prognostic

120 ± 90 ms (110.4 ms in LVP+ vs. 56.8 ms in LVP-, p index assessing the long-term mortality of 553 patients
= 0.05), QRSdc = 32 ± 27 ms (23.8 ms in LVP+ vs. with class I-III NYHA heart failure from the UK12.16 ms in LVP-, p = 0.05), QRSmax = 50 ± 30 ms HEART study (14). Mean QRSd was 44.6 ± 15.5 ms,
(43.8 ms in LVP+ vs. 30.83 ms in LVP-, p = 0.048), median was 42.7 ms, range 12 – 125 ms. In survivors
QRSmin 17 ± 11 ms (18.9 ms in LVP+ vs. 18.66 ms in QRSd was 40.6 ms compared with 45.1 ms in nonLVP-, p = ns). QRSd correlated with SAECG QRS survivors (geometric means, p = 0.003). QRSd was an
duration (r = 0.61, Bravais-Pearson) and LAS40 (r = independent predictor of all-cause mortality with a
0.78). QRSdc correlated with SAECG QRS duration (r = hazard ratio of 1.06 (1.02 – 1.1), p = 0.004. The
0.48) and LAS40 (r = 0.78). QRSmax correlated with following predictors of mortality were included in the
SAECG QRS duration (r = 0.61) and LAS40 (r = 0.72). score, with one point each: serum sodium ≥ 140 mmol/l,
Other indices had weak correlations. Given the small creatinine ≥ 111 mmol/l, cardiothoracic ratio ≥ 0.52,
number of patients, the significance of the results to the SDNN ≥ 112 ms, maximum QTc ≥ 487 ms, QRS
larger population remains unclear.
QRD dispersion in heart failure

dispersion ≥ 42.7 ms, the presence of non-sustained VT
on 24-hours Holter recordings and LV hypertrophy in

Anastasiou-Nana et al. followed 104 class II-IV 12-lead ECG. In the low-risk group (0–3 points)
NYHA heart failure patients with systolic dysfunction mortality at 5 years was 20% compared to 53% in the
(left ventricular ejection fraction < 35%) for 20 ± 12 high-risk group (4–8 points). The study was developed
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before the era of beta-blockers in heart failure started, so patients with CRT device implant were divided by Qiao
the results need to be confirmed with current standards- and colleagues into three groups: non-responders (n =
of-care. Another point worth mentioning is the need to 23), responders (n = 37) and super-responders (n = 16)
compare this prognostic score with other well- (16). Responders met all the following criteria: no
established easy-to-obtain risk variables, including left cardiovascular death, no heart transplantation, no
ventricular ejection fraction, given the fact that this score hospitalization for decompensated heart failure, and
included a time-consuming mix of blood tests, imaging, improvement of NYHA class. A patient was classified as
a super-responder if LVEF was ≥ 50% at follow-up.

and electrocardiographic techniques.
QRD dispersion in left bundle branch block

QRS duration and dispersion were measured on standard

Wyndham et al. showed that in patients with left 12-lead ECGs at a paper speed of 25 mm/s before and
bundle branch block (LBBB), the onset of ventricular immediately after the implantation. Pre-implant QRSd
epicardial activation is closer to anterior right ventricle was 49.5 ± 18.1 ms in non-responders, 43.5 ± 17.0 ms in
than in normal activation, with slow trans-septal responders, 38.7 ± 19.2 in super-responders (p = ns).
activation of LV (7).

Post-implant QRSd was 40.1 ± 27.9 ms in non-

Xiao et al. studied the correlation between QRSd responders, 32.9 ± 21.5 ms in responders, 25.0 ± 15.9 ms
and LV function and the asynchrony of ventricular in super-responders (p < 0.05 compared with nonmotion in patients with LBBB (15). Forty-two patients responders). In a multivariate analysis, none of the
with LBBB and 28 normal controls (group C) were variables was independently associated with CRT nonincluded. The LBBB patients were divided into two response.
groups: the isolated LBBB patients (group A, n = 7), and

However, other authors found that, unlike QRS

LBBB patients with other organic diseases (group B, n = maximum duration, QRSd was not a significant
35). All the indices were significantly different between predictor of maximum hemodynamic change in patients
group B and group C (p < 0.05), except for LVEF. All that have undergone cardiac resynchronization therapy
the indices were significantly different between group A (17).
and group B, except for QRS duration. The QRS

Dilaveris et al. studied the effects of biventricular

duration and QRSd were negatively correlated with LV pacing on ventricular depolarization and repolarization
ejection fraction in the two LBBB groups, with the (by ECG and vectorcardiography) (18). They found QRS
correlation of r = -0.310 (p = 0.046) for QRS duration duration and dispersion significantly decreased as effect
and r = -0.341 (p = 0.027) for QRSd; QRSd and LV of resynchronization therapy.
systolic

asynchrony

index

(evaluated

by

echo-

Chávez-González et al. selected 19 patients with

cardiography) were positively correlated, with the LBBB, LVEF ≤ 35% and resynchronization therapy
correlation of r = 0.318 (p = 0.040).

(19). QRSd was higher in women (48.0 ± 24.0 ms vs.

Is QRS dispersion a potential predictor of response 37.14 ± 13.8 ms; p=0.04) and decreased after
to cardiac resynchronization therapy?

resynchronization, especially in responders. There was a

QRS duration and morphology are important criteria linear correlation between LVEF and QRSd (r=0.34,
for the indication of cardiac resynchronization therapy p=0.02 at six months follow-up). Considering this
implantation. In this setting, QRSd was investigated as a research, the same group proposes that besides duration,
possible marker of therapy response. Seventy-six QRS

dispersion

should

be

measured

in

future
136
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investigations about resynchronization therapy, in order

QRS dispersion has been proposed as a criterion for

to reach better predicting indexes for such electrical the diagnosis of ARVC. Turrini and colleagues
therapy (20).
QRS dispersion in cardiomyopathies

investigated the value of QRSd as a noninvasive marker
of sudden death in 20 sudden death victims with ARVC

Arrhythmogenic right ventricular cardiomyopathy diagnosed at autopsy (group I), 20 living ARVC patients
(ARVC) is an inherited disease in which there is a with sustained VT (group II), 20 living ARVC patients
gradual replacement of ventricular myocardium with with ≤ 3 consecutive premature ventricular beats (group
fibro-fatty tissue, initially predominantly in the right III), and 20 control subjects (group IV) (22). QRSd was
ventricle, with its main feature being the risk of greater in group I compared with group II (45.7 ± 8.1 ms
malignant ventricular arrhythmias. The replacement of vs. 33.5 ± 8.7 ms, p = 0.0004) and in group II compared
cardiomyocytes with adipose or fibro-fatty tissue with group III (33.5 ± 8.7 ms vs. 28 ± 5.2 ms, p <
determines the development of viable myocardium 0.0001) and group IV (33.5 ± 8.7 ms vs. 18.5 ± 3.6 ms, p
islands surrounded by inert areas, with severely altered < 0.0001). A QRSd ≥ 40 ms had a sensitivity of 90% and
electrical continuity. The isolated areas are depolarizing a specificity of 77% in identifying patients at risk of
significantly later than normal ones and induce QRS sudden death. QRS dispersion was the only independent
duration prolongation in leads facing directly the predictor of sudden death in a multivariate analysis,
affected area (i.e., usually V1-V3), with increased QRS excepting a history of syncope (odds ratio 1.22, CI 1.11 dispersion, or if the conduction is even slower, the 1.35; p < 0.0001) (22).
appearance of a low-amplitude signal at the end of QRS
complex (ε - epsilon wave).

The value of QRSd as an independent predictor of
sudden death in ARVC has been confirmed in other

To be visible as a separate wave on the surface ECG, studies. Nasir and co-workers analyzed a number of
this late depolarizing area must have a sufficient size and ECG characteristics in 50 patients with ARVC, 50
must depolarize uniformly though later than in the case matched controls, and 28 patients with right ventricular
outflow tract tachycardia (23). QRSd ≥ 40 ms was
of a block of one of the His-Purkinje network bundles.
present in 44% of patients with ARVC without right
The diagnosis of ARVC is established with the 2010
bundle branch block (RBBB) vs. 4% in right ventricular
Task Force Criteria, and includes the following types of
outflow tract (RVOT) tachycardia group (p < 0.0001) vs.
findings: global and/or regional myocardial dysfunction
0% in normal controls (p < 0.0001). The presence of
and structural abnormalities in imaging assessment,
RBBB had no influence on dispersion. In patients
histopathology (endomyocardial biopsy), repolarization
without RBBB the only significant predictors of
abnormalities on 12-lead ECG, depolarization
inducibility of VT at EPS after logistic regression
abnormalities on 12-lead ECG, arrhythmias, family analysis were prolonged S-wave upstroke in V1 through
history and genetics (21). Depolarization abnormalities V3 ≥ 70 ms (odds ratio 7.2; 95% CI 1.2 - 43.8; p = 0.03)
included are: ε wave in V1–3 (reproducible low- and QRS dispersion ≥ 40 ms (odds ratio 6.1; 95% CI 1.0
amplitude signals between end of QRS complex to onset - 37.6; P = 0.05). It has been reported that a QRS
of the T wave, major criterion), and signal-averaged dispersion ≥ 50 ms was a predictor of recurrent
ECG with late potentials (if QRS on standard surface arrhythmic events in a cohort of 121 consecutive patients
ECG < 110 ms, minor criterion) (21).

(24). Hulot et al. confirmed the value of QRS dispersion
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as a risk factor for cardiovascular death in a cohort of CMR and QRS dispersion in 40 consecutive patients
130 patients (100 men; age at onset of symptoms, 31.8 ± (27). Using the cut-off value of 40 ms for QRSd
14.4 years) followed-up 8.1 ± 7.8 years (25). QRS separated the patients in two groups with significant
dispersion > 40 ms was recorded in 40% of the patients structural differences. Patients with QRSd ≥ 40 ms had
and was significantly more frequent in the group with higher dimensions of right ventricle function: endcardiovascular death compared with the group of diastolic diameter (57 ± 10 mm vs. 48 ± 11 mm, p =
survivors or with non-cardiovascular death (57.1% vs. 0.012), end-systolic diameter (52 ± 10 mm vs. 44 ± 11
36.7%, p = 0.08). QRS dispersion > 40 ms was a mm, p = 0.010), end-diastolic volume (260 ± 105 ml vs.
predictor of cardiovascular death (OR = 2.30, 0.89 - 180 ± 66 ml, p = 0.006), end-systolic volume (222 ± 98
5.95, p = 0.08) comparable with recurrence of ml vs. 148 ± 61 ml, p = 0.006) and higher myocardial
ventricular tachycardia. The best predictor was the fibrosis detection rate (74% vs. 38%, p = 0.024).
presence of right heart failure (odds ratio = 10.99) (25).
Electrocardiographic

abnormalities

in

Analyzing the group as a whole, QRS dispersion

ARVC, correlated significantly with right ventricular end-

including QRS dispersion, are dynamic features of diastolic volume (r = 0.66, p < 0.001), right ventricular
ARVC, as was demonstrated in a study on 317 ECGs end-systolic volume (r = 0.67, p < 0.001), right
from 68 genotyped patients (34 with disease-causing ventricular outflow tract area (r = 0.68, p < 0.001) (27).
mutations) during follow-up of 34 ± 28 months (26). In

Hypertrophic

cardiomyopathy

is

another

this cohort, 23% of patients had new or dynamic ECG arrhythmogenic disease in which simple, specific and
changes. ECG changes present at baseline were: T wave sensitive ECG risk markers are needed. QRS dispersion
inversion beyond V2 (39.7%), epsilon waves (5.9%), was tested, but only indirectly and in a small number of
localized prolongation of the QRS complex in V1-V3 patients. Sakata et al., in a retrospective analysis of
(14.7%), and QRS dispersion ≥ 40 ms (10.3%). QRS echocardiography and electrocardiography in 70 patients
dispersion was relatively stable during follow-up with no with hypertrophic cardiomyopathy, did not find a
significant changes in 89.7% without QRSd at baseline correlation between QRS duration or dispersion and the
and 8.8% of patients with QRSd at baseline. Very distribution of LV hypertrophy (28). The relationship
interestingly, in one patient QRSd was present at with wall thickness was not tested. Kawasaki et al.
baseline but normalized during follow-up, due to QRS enrolled 70 patients with hypertrophic cardiomyopathy
prolongation in left precordial leads, supposedly through and anteroseptal wall hypertrophy, 8 patients with lateral
left ventricular involvement. This evolution of QRSd is wall hypertrophy, 8 patients with diffuse hypertrophy,
consistent with the hypothesis of a correlation between and 46 normal controls (29). Standard 12-lead ECG
electrocardiographic dispersion and structural changes in parameters were analyzed. QRS dispersion was highest
the myocardium, but also suggests that in more in the group with anteroseptal hypertrophy (43.0 ± 10.6
advanced disease states with bi-ventricular involvement, ms), followed by the group with lateral wall hypertrophy
QRSd may lose sensitivity (26).

(32.9 ± 11.9 ms). In these patients, there was a

Cardiac magnetic resonance (CMR) imaging is an superposition of localization of QRS increased duration
important tool for diagnosis of ARVC. A study by Ma with the echocardiographic disposition of hypertrophy.
and colleagues assessed the correlations between the The group with diffuse hypertrophy was not different
presence of right ventricular abnormalities detected by from controls. QRS dispersion was not significantly
138
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different in patients with or without markers of risk 5. Durrer D, van Dam RT, Freud GE, Janse MJ,
(syncope, ventricular tachycardia, cardiac events), or

Meijler FL, Arzbaecher RC. Total excitation

between patients of different NYHA functional class

of the isolated human heart. Circulation. 1970;

(29).

41(6):

PMID:

5482907,

DOI:

10.1161/01.CIR.41.6.899

Conclusions

6. Cassidy DM, Vassallo JA, Marchlinski FE, Buxton

As a conclusion, the QRS dispersion is a simple
electrocardiographic marker with potential value in the
assessment of patients in different clinical settings:
ischemic

899-912.

heart

disease,

heart

failure,

and

cardiomyopathies. More studies are needed to validate
its clinical utility for predicting the risk for ventricular
arrhythmias and sudden cardiac death, and for the
evaluation of the response to cardiac resynchronization
therapy.
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